No insider purchase over the last 90 days. The latest, by 정현규, was filed 02 Apr 2026.
Who traded when
BuySaleSince the insiders bought
- -39.0%Entry ₩5,250 · Close 30 Oct 2026 ₩3,200
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 422,924 sharesKRXDART:20260402000955Canonical exit: 28 Jun 2026 (T+90)
- ●Executives0DART
- 8,200 sharesShareKRXDART:20260204000112Canonical exit: 5 May 2026 (T+90)
- 330,333 sharesShareKRXDART:20260126000424Canonical exit: 26 Apr 2026 (T+90)
- 651,105 sharesKRXDART:20260108000156
- 165,962 sharesKRXDART:20250902000326Canonical exit: 24 Nov 2025 (T+90)
- 33,332 sharesKRXDART:20250109000141
- 826,774 sharesKRXDART:20241230000437
- 20,000 sharesShareKRXDART:20241118000005Canonical exit: 16 Feb 2025 (T+90)
- 70,000 sharesKRXDART:20241118000004Canonical exit: 12 Feb 2025 (T+90)
- 100,000 sharesShareKRXDART:20241108000106Canonical exit: 6 Feb 2025 (T+90)
- 100,000 sharesKRXDART:20241107000047Canonical exit: 29 Jan 2025 (T+90)
- ShareKRXDART:20241107000050
- 0KRXDART:20241010000346
- 232,188 sharesKRXDART:20240906000455
- ShareKRXDART:20240906000472
- 1,526,717 sharesKRXDART:20240731000707Canonical exit: 29 Oct 2024 (T+90)
- 3,395,579 sharesKRXDART:20240729000052Canonical exit: 23 Oct 2024 (T+90)
- ShareKRXDART:20240724000061
- 0KRXDART:20240724000057
- 152,040 sharesKRXDART:20240710000355Canonical exit: 26 Sept 2024 (T+90)
- 50,000 sharesKRXDART:20240612000051Canonical exit: 2 Sept 2024 (T+90)
- ShareKRXDART:20240612000055Canonical exit: 2 Sept 2024 (T+90)
- 1,833,837 sharesKRXDART:20240607000171
25 of 60 declarations
About Bio Plus Co., Ltd
Sales prevail at 바이오플러스 (Bio Plus Co., Ltd): 19, against 13 purchases, so 41% of open-market trades are purchases. The only sale with an amount is by 박성복, EUR 528,822 on January 4, 2023. 이해영 files 11, all sales. 정현규 (대표이사) is the top filer with 37 of the 59 filings, including 9 purchases and 3 sales. 한국증권금융 (대량보유자) and 린드먼아시아 have 3 filings each, and the company 2, with no trade.
From January 26 to February 4, 2026, 2 distinct filers bought. No purchase carries an amount. The record runs from September 30, 2021 to April 2, 2026: 9 filings in 2021, 16 in 2022, 9 in 2023, 18 in 2024, 2 in 2025 and 5 in 2026. As many as 27 filings are neither purchases nor sales.
Read moreShow less
South Korean health care, KRW 227.1 billion of capitalisation, 29.8% of the capital with insiders (8 filers). The latest year: 5 filings, 3 purchases and one sale. Publication delay at the median: 7 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
